•
Dec 30, 2024

Black Diamond Therapeutics Q4 2024 Earnings Report

Expected Revenue:$0
Expected EPS:-$0.31
+34.0% YoY
Total Revenue
$0
Previous year: $4.89M
-100.0%
Gross Profit
-$85K
Previous year: $4.81M
-101.8%
Cash and Equivalents
$98.6M
Previous year: $131M
-25.0%
Free Cash Flow
-$15.1M
Previous year: -$14M
+7.9%
Total Assets
$123M
Previous year: $159M
-22.7%

Black Diamond Therapeutics

Black Diamond Therapeutics